Cosmos Holdings Inc. (COSM)
| Market Cap | 19.66M |
| Revenue (ttm) | 57.69M |
| Net Income (ttm) | -19.01M |
| Shares Out | 18.72M |
| EPS (ttm) | -1.11 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 97,733 |
| Open | 1.13 |
| Previous Close | 1.12 |
| Day's Range | 1.00 - 1.13 |
| 52-Week Range | 0.75 - 7.77 |
| Beta | 1.13 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 16, 2022 |
About COSM
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, health care, baby products, medical devices, and other products through its distribution channels and e-commerce market place. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece, and the United Kingdom; and warehousing facility. It serves w...
Financial Performance
Financial StatementsNews
Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the ...
Reports Positive Net Income of $0.2 Million and $1.2 Million of EBITDA for the First Quarter of 2022 CHICAGO, IL / ACCESSWIRE / May 18, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an in...
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Canada
First commercial launch of nutraceutical products in North American Market CHICAGO, IL / ACCESSWIRE / May 5, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM) , an international pharmaceutical ...
Cosmos Holdings Appoints Finance Veteran Dr. Anastasios Aslidis to the Board of Directors and as a Member of the Boar...
CHICAGO, IL / ACCESSWIRE / May 3, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of brande...
COSM Stock Alert: 7 Things to Know About Red-Hot Cosmos Holdings
Cosmos Holdings (COSM) stock is seeing major gains on Wednesday with heavy trading despite a lack of recent news from the company. The post COSM Stock Alert: 7 Things to Know About Red-Hot Cosmos Holdin...
Best Penny Stocks to Buy Today? 3 Climbing In Morning Trading
Here's what you need to know about trading penny stocks on April 27th The post Best Penny Stocks to Buy Today? 3 Climbing In Morning Trading appeared first on Penny Stocks to Buy, Picks, News and Infor...
Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021
CHICAGO, IL / ACCESSWIRE / April 19, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bra...
Cosmos Holdings Launches Mediterranation, a New Premium Nutritional Supplements Line
New line contains unique formulations and ingredients found in specific regions in Greece and the Mediterranean CHICAGO, IL / ACCESSWIRE / April 12, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:...
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Singapore
CHICAGO, IL / ACCESSWIRE / April 5, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bran...
Cosmos Holdings Launches Proprietary Sky Premium Life Brainlit Supplement for Brain Health
Designed to support and enhance brain function CHICAGO, IL / ACCESSWIRE / March 31, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietar...
Cosmos Holdings Launches Proprietary Sky Premium Life Prostatium Supplement for Prostate Health
Designed to prevent and protect against Benign Prostate Hyperplasia, which affects millions of men worldwide CHICAGO, IL / ACCESSWIRE / March 28, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COS...
Cosmos Holdings to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
CHICAGO, IL / ACCESSWIRE / March 24, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bra...
Cosmos Holdings CEO Provides Letter to Shareholders
CHICAGO, IL / ACCESSWIRE / March 23, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bra...
Cosmos Holdings to Ring Closing Bell Today to Celebrate Milestone NASDAQ Listing
CHICAGO, IL / ACCESSWIRE / March 11, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bra...
Cosmos Holdings Announces Closing of $6 Million Private Placement of Convertible Preferred Stock and Start of Trading...
CHICAGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (Nasdaq: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bran...
Cosmos Holdings Announces Shareholder Approval of Private Offering
CHICAGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of br...
Cosmos Holdings Achieves Positive Adjusted Net Income and Positive Adjusted EBITDA for the Third Quarter of 2021
CHICAGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bran...
Cosmos Holdings Announces Installation of State-of-the-Art Automated Fulfillment System to Maximize the Productivity ...
CHICAGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bran...
Cosmos Holdings Secures $5.5M Investment From Ault Global
Ault Global Holdings Inc (NYSE: DPW) subsidiary entered into agreements for investments of ~$5.5 million in pharmaceutical company Cosmos Holdings, Inc. (OTC: COSM). The first investment, a convertible ...
UPDATE - Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings
Received initial bridge financing for proceeds of approximately $500,000 plus an additional $5.0 million of Series A Preferred Stock upon approval of Nasdaq listing Received initial bridge financing for...
Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings
Received initial bridge financing for proceeds of approximately $500,000 plus an additional $5.0 million of Series A Preferred Stock upon approval of Nasdaq listing Received initial bridge financing for...
Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company's Senior Lender, Further Enhancing th...
CHICAGO, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, n...
Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter o...
CHICAGO, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutr...
Cosmos Holdings to Open Flagship Store on Alibaba's Tmall Global, World's Largest Cross-Border E-Commerce Marketplace...
Company Partners with Leading China E-Commerce Solutions Provider REMAI to Launch Sky Premium Life Products on Tmall Global Company Partners with Leading China E-Commerce Solutions Provider REMAI to Lau...
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share
CEO has converted $4.0 million of the Company's debt to date; the conversion price represents a premium to market CEO has converted $4.0 million of the Company's debt to date; the conversion price repre...
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share
The conversion price represents a premium to market The conversion price represents a premium to market